Literature DB >> 29435570

Tau Positron Emission Tomography in Autosomal Dominant Alzheimer Disease: Small Windows, Big Picture.

Eric McDade1, Randall J Bateman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29435570      PMCID： PMC5970084          DOI： 10.1001/jamaneurol.2017.4026

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  11 in total

1.  Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.

Authors:  Aaron P Schultz; Jasmeer P Chhatwal; Trey Hedden; Elizabeth C Mormino; Bernard J Hanseeuw; Jorge Sepulcre; Willem Huijbers; Molly LaPoint; Rachel F Buckley; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2017-03-17       Impact factor: 6.167

2.  Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.

Authors:  Adam S Fleisher; Kewei Chen; Yakeel T Quiroz; Laura J Jakimovich; Madelyn Gutierrez Gomez; Carolyn M Langois; Jessica B S Langbaum; Auttawut Roontiva; Pradeep Thiyyagura; Wendy Lee; Napatkamon Ayutyanont; Liliana Lopez; Sonia Moreno; Claudia Muñoz; Victoria Tirado; Natalia Acosta-Baena; Anne M Fagan; Margarita Giraldo; Gloria Garcia; Matthew J Huentelman; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

3.  Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain.

Authors:  Jorge Sepulcre; Mert R Sabuncu; Quanzheng Li; Georges El Fakhri; Reisa Sperling; Keith A Johnson
Journal:  Alzheimers Dement       Date:  2017-03-30       Impact factor: 21.566

Review 4.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

5.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

6.  PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

Authors:  Kurt A Jellinger; Irina Alafuzoff; Johannes Attems; Thomas G Beach; Nigel J Cairns; John F Crary; Dennis W Dickson; Patrick R Hof; Bradley T Hyman; Clifford R Jack; Gregory A Jicha; David S Knopman; Gabor G Kovacs; Ian R Mackenzie; Eliezer Masliah; Thomas J Montine; Peter T Nelson; Frederick Schmitt; Julie A Schneider; Albert Serrano-Pozo; Dietmar R Thal; Jonathan B Toledo; John Q Trojanowski; Juan C Troncoso; Jean Paul Vonsattel; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2015-03-17       Impact factor: 17.088

7.  Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy.

Authors:  Liang Wang; Tammie L Benzinger; Yi Su; Jon Christensen; Karl Friedrichsen; Patricia Aldea; Jonathan McConathy; Nigel J Cairns; Anne M Fagan; John C Morris; Beau M Ances
Journal:  JAMA Neurol       Date:  2016-09-01       Impact factor: 18.302

8.  Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

Authors:  Nicolas R Barthélemy; François Fenaille; Christophe Hirtz; Nicolas Sergeant; Susanna Schraen-Maschke; Jérôme Vialaret; Luc Buée; Audrey Gabelle; Christophe Junot; Sylvain Lehmann; François Becher
Journal:  J Proteome Res       Date:  2016-01-19       Impact factor: 4.466

9.  Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly.

Authors:  Jasmeer P Chhatwal; Aaron P Schultz; Gad A Marshall; Brendon Boot; Teresa Gomez-Isla; Julien Dumurgier; Molly LaPoint; Clemens Scherzer; Allyson D Roe; Bradley T Hyman; Reisa A Sperling; Keith A Johnson
Journal:  Neurology       Date:  2016-07-29       Impact factor: 9.910

10.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501
View more
  10 in total

1.  Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer's Disease.

Authors:  Jin-Zhou Tian; Jing Shi; Jing-Nian Ni; Ming-Qing Wei; Xue-Kai Zhang; Ke-Ji Chen; Yong-Yan Wang
Journal:  Chin J Integr Med       Date:  2019-05-07       Impact factor: 1.978

2.  Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.

Authors:  Heidi I L Jacobs; John Alex Becker; Kenneth Kwong; Diana Munera; Liliana Ramirez-Gomez; Nina Engels-Domínguez; Justin S Sanchez; Clara Vila-Castelar; Ana Baena; Reisa A Sperling; Keith A Johnson; Francisco Lopera; Yakeel T Quiroz
Journal:  Alzheimers Dement       Date:  2022-03-17       Impact factor: 16.655

Review 3.  Alzheimer's disease associated with Down syndrome: a genetic form of dementia.

Authors:  Juan Fortea; Shahid H Zaman; Sigan Hartley; Michael S Rafii; Elizabeth Head; Maria Carmona-Iragui
Journal:  Lancet Neurol       Date:  2021-11       Impact factor: 59.935

Review 4.  Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.

Authors:  C Frank Bennett; Adrian R Krainer; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2019-07-08       Impact factor: 12.449

Review 5.  Tau PET imaging in neurodegenerative tauopathies-still a challenge.

Authors:  Antoine Leuzy; Konstantinos Chiotis; Laetitia Lemoine; Per-Göran Gillberg; Ove Almkvist; Elena Rodriguez-Vieitez; Agneta Nordberg
Journal:  Mol Psychiatry       Date:  2019-01-11       Impact factor: 15.992

Review 6.  Biomarkers of dementia in obstructive sleep apnea.

Authors:  Andrée-Ann Baril; Julie Carrier; Alexandre Lafrenière; Simon Warby; Judes Poirier; Ricardo S Osorio; Najib Ayas; Marie-Pierre Dubé; Dominique Petit; Nadia Gosselin
Journal:  Sleep Med Rev       Date:  2018-08-13       Impact factor: 11.609

7.  Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.

Authors:  Antoine Leuzy; Ruben Smith; Rik Ossenkoppele; Alexander Santillo; Edilio Borroni; Gregory Klein; Tomas Ohlsson; Jonas Jögi; Sebastian Palmqvist; Niklas Mattsson-Carlgren; Olof Strandberg; Erik Stomrud; Oskar Hansson
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

8.  Predicting future rates of tau accumulation on PET.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Terry M Therneau; Val J Lowe; David S Knopman; Hugo Botha; Jonathan Graff-Radford; David T Jones; Tanis J Ferman; Bradley F Boeve; Kejal Kantarci; Prashanthi Vemuri; Michelle M Mielke; Jennifer Whitwell; Keith Josephs; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Ronald C Petersen
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

9.  Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.

Authors:  Matthew John Mold; Adam O'Farrell; Benjamin Morris; Christopher Exley
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  Aluminum and Tau in Neurofibrillary Tangles in Familial Alzheimer's Disease.

Authors:  Matthew John Mold; Adam O'Farrell; Benjamin Morris; Christopher Exley
Journal:  J Alzheimers Dis Rep       Date:  2021-04-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.